Graviton Bioscience
Biotechnology, clinical stage, CNC, autoimmune, fibrotic indications
Graviton Bioscience is active in the biotechnology, therapeutics space based in Greater New York Area, East Coast, Northeastern US, founded in 2020.
Its activity falls under biotechnology, therapeutics; the profile below is assembled from public directory data.
The company is recorded as being based in Greater New York Area, East Coast, Northeastern US.
It is recorded at the Private_Equity stage.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $64.8M in funding.
| Sector | Biotechnology, Therapeutics |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2020 |
| Employees | c_00011_00050 |
| Stage | private_equity |
| Total funding | $64,819,494 |
Website: gravitoncorp.com
Sign in to view the contact information we hold for Graviton Bioscience.
Create a free account
Create a free account